356 related articles for article (PubMed ID: 25843761)
1. Amorphous solid dispersions of piroxicam and Soluplus(®): Qualitative and quantitative analysis of piroxicam recrystallization during storage.
Lust A; Strachan CJ; Veski P; Aaltonen J; Heinämäki J; Yliruusi J; Kogermann K
Int J Pharm; 2015; 486(1-2):306-14. PubMed ID: 25843761
[TBL] [Abstract][Full Text] [Related]
2. Thermoanalytical and Fourier transform infrared spectral curve-fitting techniques used to investigate the amorphous indomethacin formation and its physical stability in Indomethacin-Soluplus® solid dispersions.
Lin SY; Lin HL; Chi YT; Huang YT; Kao CY; Hsieh WH
Int J Pharm; 2015 Dec; 496(2):457-65. PubMed ID: 26481469
[TBL] [Abstract][Full Text] [Related]
3. A comparison of the effect of temperature and moisture on the solid dispersions: aging and crystallization.
Tian B; Zhang L; Pan Z; Gou J; Zhang Y; Tang X
Int J Pharm; 2014 Nov; 475(1-2):385-92. PubMed ID: 25218489
[TBL] [Abstract][Full Text] [Related]
4. Stability-enhanced hot-melt extruded amorphous solid dispersions via combinations of Soluplus® and HPMCAS-HF.
Alshahrani SM; Lu W; Park JB; Morott JT; Alsulays BB; Majumdar S; Langley N; Kolter K; Gryczke A; Repka MA
AAPS PharmSciTech; 2015 Aug; 16(4):824-34. PubMed ID: 25567525
[TBL] [Abstract][Full Text] [Related]
5. An investigation of nifedipine miscibility in solid dispersions using Raman spectroscopy.
Keratichewanun S; Yoshihashi Y; Sutanthavibul N; Terada K; Chatchawalsaisin J
Pharm Res; 2015 Jul; 32(7):2458-73. PubMed ID: 25673042
[TBL] [Abstract][Full Text] [Related]
6. Improvement in the water solubility of drugs with a solid dispersion system by spray drying and hot-melt extrusion with using the amphiphilic polyvinyl caprolactam-polyvinyl acetate-polyethylene glycol graft copolymer and d-mannitol.
Ogawa N; Hiramatsu T; Suzuki R; Okamoto R; Shibagaki K; Fujita K; Takahashi C; Kawashima Y; Yamamoto H
Eur J Pharm Sci; 2018 Jan; 111():205-214. PubMed ID: 28893625
[TBL] [Abstract][Full Text] [Related]
7. Molecular interaction between glimepiride and Soluplus®-PEG 4000 hybrid based solid dispersions: Characterisation and anti-diabetic studies.
Reginald-Opara JN; Attama A; Ofokansi K; Umeyor C; Kenechukwu F
Int J Pharm; 2015 Dec; 496(2):741-50. PubMed ID: 26581773
[TBL] [Abstract][Full Text] [Related]
8. Evaluation and enhancement of physical stability of semi-solid dispersions containing piroxicam into hard gelatin capsules.
Karataş A; Bekmezci S
Acta Pol Pharm; 2013; 70(5):883-97. PubMed ID: 24147368
[TBL] [Abstract][Full Text] [Related]
9. Towards improved solubility of poorly water-soluble drugs: cryogenic co-grinding of piroxicam with carrier polymers.
Penkina A; Semjonov K; Hakola M; Vuorinen S; Repo T; Yliruusi J; Aruväli J; Kogermann K; Veski P; Heinämäki J
Drug Dev Ind Pharm; 2016; 42(3):378-88. PubMed ID: 26065533
[TBL] [Abstract][Full Text] [Related]
10. On the inherent properties of Soluplus and its application in ibuprofen solid dispersions generated by microwave-quench cooling technology.
Shi NQ; Lai HW; Zhang Y; Feng B; Xiao X; Zhang HM; Li ZQ; Qi XR
Pharm Dev Technol; 2018 Jul; 23(6):573-586. PubMed ID: 27824281
[TBL] [Abstract][Full Text] [Related]
11. Solid molecular dispersions of poorly water-soluble drugs in poly(2-hydroxyethyl methacrylate) hydrogels.
Zahedi P; Lee PI
Eur J Pharm Biopharm; 2007 Mar; 65(3):320-8. PubMed ID: 17182231
[TBL] [Abstract][Full Text] [Related]
12. Effect of storage on the physical stability of thin polymethacrylate-perphenazine films.
Korhonen K; Smolander E; Korhonen O; Ketolainen J; Laitinen R
Eur J Pharm Sci; 2017 Jun; 104():293-301. PubMed ID: 28342783
[TBL] [Abstract][Full Text] [Related]
13. Studies on aging piroxicam-polyvinylpyrrolidone solid dispersions.
Ingkatawornwong S; Kaewnopparat N; Tantishaiyakul V
Pharmazie; 2001 Mar; 56(3):227-30. PubMed ID: 11265589
[TBL] [Abstract][Full Text] [Related]
14. Non-invasive insight into the release mechanisms of a poorly soluble drug from amorphous solid dispersions by confocal Raman microscopy.
Punčochová K; Vukosavljevic B; Hanuš J; Beránek J; Windbergs M; Štěpánek F
Eur J Pharm Biopharm; 2016 Apr; 101():119-25. PubMed ID: 26861928
[TBL] [Abstract][Full Text] [Related]
15. Dissolution enhancement of felodipine by amorphous nanodispersions using an amphiphilic polymer: insight into the role of drug-polymer interactions on drug dissolution.
Pandey MM; Jaipal A; Charde SY; Goel P; Kumar L
Pharm Dev Technol; 2016; 21(4):463-74. PubMed ID: 25777532
[TBL] [Abstract][Full Text] [Related]
16. Solubility and dissolution performances of spray-dried solid dispersion of Efavirenz in Soluplus.
Lavra ZM; Pereira de Santana D; Ré MI
Drug Dev Ind Pharm; 2017 Jan; 43(1):42-54. PubMed ID: 27349377
[TBL] [Abstract][Full Text] [Related]
17. Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
Maghsoodi M; Sadeghpoor F
Drug Dev Ind Pharm; 2010 Aug; 36(8):917-25. PubMed ID: 20180658
[TBL] [Abstract][Full Text] [Related]
18. Polymorphic form of piroxicam influences the performance of amorphous material prepared by ball-milling.
Naelapää K; Boetker JP; Veski P; Rantanen J; Rades T; Kogermann K
Int J Pharm; 2012 Jun; 429(1-2):69-77. PubMed ID: 22433471
[TBL] [Abstract][Full Text] [Related]
19. Electrospun nanofibers as a potential controlled-release solid dispersion system for poorly water-soluble drugs.
Paaver U; Heinämäki J; Laidmäe I; Lust A; Kozlova J; Sillaste E; Kirsimäe K; Veski P; Kogermann K
Int J Pharm; 2015 Feb; 479(1):252-60. PubMed ID: 25549852
[TBL] [Abstract][Full Text] [Related]
20. Determination of drug-polymer solubility from supersaturated spray-dried amorphous solid dispersions: A case study with Efavirenz and Soluplus®.
Costa BLA; Sauceau M; Del Confetto S; Sescousse R; Ré MI
Eur J Pharm Biopharm; 2019 Sep; 142():300-306. PubMed ID: 31247317
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
